Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 45

Sleep loss and circadian misalignment and insulin resistance: how cortisol timing might help

Official title: Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Run by Washington State University · NCT07494084 · Data updated 2026-11-12

This study tests whether changing cortisol timing with hormones and sleep schedules can influence insulin resistance in healthy adults who sleep restrictively.

More Insulin Resistance trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment48 (estimated)
SponsorWashington State University
Academic / other
Locations1 site (Spokane, Washington)
StatusRecruiting
StartedJuly 16, 2026
Main results expectedMarch 2029
Study endsJuly 2029
Registry record updatedSeptember 18, 2026
Trial IDNCT07494084 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–45 with stable BMI 18–25 kg/m2, not on medications, and with regular menstrual cycles for women.

Probably not a fit

Individuals with obesity, diabetes, hormonal disorders, smoking, or recent drug use may be less likely to benefit or participate safely.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates how different cortisol rhythms, controlled with medications, affect insulin sensitivity in adults under sleep restriction. Conducted in a controlled laboratory setting, the trial uses a dual-hormone clamp approach to isolate cortisol and testosterone effects on metabolism. Participants are healthy men and women aged 18–45 with normal BMI, subjected to specific sleep schedules and biochemical manipulations, to see if stabilizing hormonal signals reduces insulin resistance. The study builds on prior work showing cortisol and testosterone signaling contribute to metabolic disruption during sleep loss, now examining sex-specific roles. It is conducted at the Sleep and Performance Research Center in Spokane, with collaboration from Harbor-UCLA.

Why it matters

Potential benefit: If successful, the approach could lead to strategies that mitigate insulin resistance associated with sleep loss and shift work.

How similar studies have gone: Previous work in men showed that uncoupling cortisol and testosterone changes during sleep loss stabilized metabolism and reduced insulin resistance, but sex-specific effects needed clarification.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Must be between 18-45 years old.
2. Has a BMI of 18-25 kg/m2 stable weight over the previous 6 weeks.
3. Is physically and psychologically healthy (incl. regular menstrual cycles in women, no clinical disorders and/or illnesses). Women will be studied during the follicular phase of their menstrual cycle.

   Menstrual cycle criteria (using PMID 10941950) 18 to 25 years - Cycle variation ≤9 days 26 to 41 years - Cycle variation ≤7 days 42 to 45 years - Cycle variation ≤9 days
4. No current medical or drug treatment (to include steroids or hormones of any type including contraceptives), as assessed by questionnaire.
5. Has a negative pregnancy test (women), no clinically significant abnormalities in blood and urine, and free of traces of drugs.
6. No history of clinically relevant psychiatric illness.
7. No previous history of drug or alcohol abuse.
8. Not a current smoker.
9. No history of brain injury or of learning disability.
10. No previous adverse reaction to sleep deprivation, jet lag, shift work or any of the drugs to be administered.
11. Not vision or hearing impairment unless corrected back to normal.
12. No endocrine disorder (no abnormal thyroid function tests; no abnormal morning blood cortisol; no primary gonadal disease as indicated by serum LH or FSH concentration \> 10 or \> 15 IU/L, respectively; and no hyperprolactinemia indicated by prolactin \> 25 μg/L).
13. No sleep or circadian disorder.
14. Has good habitual sleep with regular bedtimes (between 6 and 10 hours in duration).
15. Not extreme morning- nor extreme evening-type using Horne-Ostberg Morningness-Eveningness criteria.
16. No travel across time zones within one month of entering the study.
17. No shift work within three months of entering the study.
18. No anemia (hematocrit \<38% in men, \<34% in women).
19. No blood donation within the previous 8 weeks.
20. No concurrent participation in another research study.

Where it's running

  • Sleep and Performance Research Center
    Spokane, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Peter Liu, MBBS, PhD — Lundquist Institute of Biomedical Innovation at Harbor-UCLA Medical Center
  • Study coordinator: Devon A Hansen, PhD
  • Email: devon.hansen@wsu.edu
  • Phone: 509-358-7754

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.